Variant report
Variant | nsv960425 |
---|---|
Chromosome Location | chr17:16490660-16491873 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr17:16487641..16489428-chr17:16491263..16493497,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs528935837 | chr17:16490702-16490703 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs548608578 | chr17:16490724-16490725 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs186156068 | chr17:16490730-16490731 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs531162394 | chr17:16490748-16490749 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs552059477 | chr17:16490764-16490765 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs190281781 | chr17:16490774-16490775 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs182309375 | chr17:16490790-16490791 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs138537982 | chr17:16490793-16490794 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs370744877 | chr17:16490808-16490809 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs544148823 | chr17:16490823-16490824 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs11870805 | chr17:16490883-16490884 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs536736969 | chr17:16490890-16490891 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs556642708 | chr17:16490924-16490925 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs576510221 | chr17:16490943-16490944 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs538615543 | chr17:16490944-16490945 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs72051374 | chr17:16490965-16490966 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs375761366 | chr17:16490967-16490968 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs558049053 | chr17:16490985-16490986 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs528382783 | chr17:16490988-16490989 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs560750606 | chr17:16490989-16490990 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs375027135 | chr17:16490997-16490998 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs577833603 | chr17:16491030-16491031 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs186415894 | chr17:16491041-16491042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs190465516 | chr17:16491044-16491045 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs373668878 | chr17:16491107-16491108 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs9910496 | chr17:16491156-16491157 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs562203179 | chr17:16491164-16491165 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs568028872 | chr17:16491199-16491200 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs113236142 | chr17:16491216-16491217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs546378268 | chr17:16491227-16491228 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs565598265 | chr17:16491281-16491282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs527960280 | chr17:16491300-16491301 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs550601677 | chr17:16491317-16491318 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs566670649 | chr17:16491322-16491323 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs71355512 | chr17:16491328-16491329 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs79101964 | chr17:16491329-16491330 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs398041576 | chr17:16491339-16491340 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs548052683 | chr17:16491450-16491451 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs111535202 | chr17:16491457-16491458 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs536798800 | chr17:16491480-16491481 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs550309716 | chr17:16491531-16491532 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs532478954 | chr17:16491541-16491542 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs570130970 | chr17:16491603-16491604 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs539046457 | chr17:16491604-16491605 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs35949011 | chr17:16491640-16491641 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs34046433 | chr17:16491671-16491672 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs55712237 | chr17:16491726-16491727 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs28375681 | chr17:16491766-16491767 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs181712876 | chr17:16491784-16491785 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs553601682 | chr17:16491824-16491825 | Bivalent/Poised TSS Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Chordoma | 21602918 | CNVD |
Miller-Dieker syndrome | 22283845 | CNVD |
Non-syndromic sensorineural hearing loss | 17457615 | CNVD |
Cancer | 22429812 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Breast cancer | 22028636 | CNVD |
Breast cancer | 20837533 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
colon cancer | 17210682 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Chronic lymphocytic leukemia | 17971485 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 16461572 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Moyamoya disease | 22323933 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Colorectal cancer | 21645411 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
HIV/AIDS | 17953491 | CNVD |
HIV/AIDS | 20877625 | CNVD |
Immune disease | 21076436 | CNVD |
Rheumatoid arthritis | 17953491 | CNVD |
Type 1 diabetes | 17953491 | CNVD |
HIV/AIDS | 15637236 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Neurofibromatosis | 18196300 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Breast cancer | 17001317 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Charcot-marie-tooth disease | 16463004 | CNVD |
Osteosarcoma | 22292074 | CNVD |
Breast cancer | 17603634 | CNVD |
Charcot | 16760730 | CNVD |
Mental retardation | 17901693 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
ovarian endometriomas | 16273235 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Autism | 22102821 | CNVD |
Gastric cancer | 18160780 | CNVD |
Smith-Magenis syndrome | 18923513 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Autism | 22492990 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 18414209 | CNVD |
Developmental delay | 21549014 | CNVD |
Epilepsy | 20970697 | CNVD |
Mental retardation | 18414209 | CNVD |
Mental retardation | 21549014 | CNVD |
Smith-Magenis syndrome | 21981782 | CNVD |
Smith-Magenis syndrome | 20188345 | CNVD |
Smith-Magenis syndrome | 16775514 | CNVD |
Smith-Magenis syndrome | 22585170 | CNVD |
Smith-Magenis syndrome | 22241247 | CNVD |
Autism | 20970697 | CNVD |
Mental retardation | 19951919 | CNVD |
Potocki-Lupski syndrome | 21271655 | CNVD |
Potocki-lupski syndrome | 17357070 | CNVD |
Potocki-lupski syndrome | 20110824 | CNVD |
Potocki-lupski syndrome | 18923514 | CNVD |
Potocki-lupski syndrome | 22241247 | CNVD |
Potocki-lupski syndrome | 20188345 | CNVD |
Schizophrenia | 21399695 | CNVD |
Mental retardation | 16773131 | CNVD |
Adenocarcinoma | 19607727 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Charcot-marie-tooth disease | 22470819 | CNVD |
Neurofibromatosis | 22470819 | CNVD |
Neuropathy | 22470819 | CNVD |
Smith-Magenis syndrome | 18301319 | CNVD |
Smith-Magenis syndrome | 17357070 | CNVD |
Smith-Magenis syndrome | 18469339 | CNVD |
Smith-Magenis syndrome | 22241097 | CNVD |
Smith-Magenis syndrome | 22470819 | CNVD |
Tourette syndrome | 18923514 | CNVD |
Type 1 diabetes | 22470819 | CNVD |
Potocki-lupski syndrome | 18469339 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Neuropathy | 17597781 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 17015230 | CNVD |
Smith-Magenis syndrome | 17597781 | CNVD |
Potocki-lupski syndrome | 18059269 | CNVD |
Potocki-lupski syndrome | 17597781 | CNVD |
Mental retardation | 17847001 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Breast cancer | 20409316 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:16488200-16491800 | Weak transcription | Pancreas | Pancrea |
2 | chr17:16488200-16492000 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
3 | chr17:16488200-16492000 | Weak transcription | Primary T helper memory cells from peripheral blood 1 | blood |
4 | chr17:16488200-16492000 | Weak transcription | Liver | Liver |
5 | chr17:16488200-16492000 | Weak transcription | Brain Anterior Caudate | brain |
6 | chr17:16488200-16492000 | Weak transcription | Brain Hippocampus Middle | brain |
7 | chr17:16488200-16492000 | Weak transcription | Brain Dorsolateral Prefrontal Cortex | brain |
8 | chr17:16488200-16492000 | Weak transcription | Brain Substantia Nigra | brain |
9 | chr17:16488200-16492000 | Weak transcription | Colon Smooth Muscle | Colon |
10 | chr17:16488200-16492000 | Weak transcription | Psoas Muscle | Psoas |
11 | chr17:16488200-16492000 | Weak transcription | Rectal Smooth Muscle | rectum |
12 | chr17:16488200-16492000 | Weak transcription | Stomach Smooth Muscle | stomach |
13 | chr17:16488200-16492200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
14 | chr17:16488200-16492200 | Weak transcription | Primary T helper memory cells from peripheral blood 2 | blood |
15 | chr17:16488200-16492200 | Weak transcription | Primary T helper naive cells from peripheral blood | blood |
16 | chr17:16488200-16492200 | Weak transcription | Primary T helper 17 cells PMA-I stimulated | -- |
17 | chr17:16488200-16492200 | Weak transcription | Primary T cells effector/memory enriched fromperipheralblood | blood |
18 | chr17:16488200-16492200 | Weak transcription | Placenta | Placenta |
19 | chr17:16488200-16492200 | Weak transcription | Left Ventricle | heart |
20 | chr17:16488200-16492200 | Weak transcription | Placenta Amnion | Placenta Amnion |
21 | chr17:16488200-16492200 | Weak transcription | Right Ventricle | heart |
22 | chr17:16488200-16492200 | Weak transcription | HMEC | breast |
23 | chr17:16488400-16492000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
24 | chr17:16488400-16492000 | Weak transcription | Brain Cingulate Gyrus | brain |
25 | chr17:16489200-16492200 | Weak transcription | Lung | lung |
26 | chr17:16489600-16492000 | Weak transcription | Adipose Nuclei | Adipose |
27 | chr17:16491800-16492000 | Bivalent/Poised TSS | iPS-15b Cell Line | embryonic stem cell |
28 | chr17:16491800-16492200 | Enhancers | Pancreas | Pancrea |
29 | chr17:16491800-16493000 | Active TSS | Brain Inferior Temporal Lobe | brain |